Informa’s (INF) “Buy” Rating Reaffirmed at Shore Capital
Shore Capital reissued their buy rating on shares of Informa (LON:INF – Free Report) in a research note issued to investors on Tuesday, Marketbeat.com reports....
Babcock International Group (LON:BAB) Given Buy Rating at Shore Capital
Shore Capital reaffirmed their buy rating on shares of Babcock International Group (LON:BAB – Free Report) in a research note published on Tuesday morning, MarketBeat...
HC Wainwright Trims Aclaris Therapeutics (NASDAQ:ACRS) Target Price to $9.00
Aclaris Therapeutics (NASDAQ:ACRS – Free Report) had its target price decreased by HC Wainwright from $43.00 to $9.00 in a research report sent to investors...
Akero Therapeutics’ (AKRO) “Buy” Rating Reiterated at HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Akero Therapeutics (NASDAQ:AKRO – Free Report) in a research report sent to investors on Tuesday morning,...
Zeta Global (NASDAQ:ZETA) Earns “Outperform” Rating from William Blair
William Blair reaffirmed their outperform rating on shares of Zeta Global (NASDAQ:ZETA – Free Report) in a research note published on Tuesday morning, RTT News...
Beyond Air (NASDAQ:XAIR) Given New $10.00 Price Target at Truist Financial
Beyond Air (NASDAQ:XAIR – Free Report) had its target price trimmed by Truist Financial from $14.00 to $10.00 in a research report released on Tuesday...